Long-term efficacy of sodium-glucose cotransporter 2 inhibitor therapy in preventing atrial fibrillation recurrence after catheter ablation in type 2 diabetes mellitus patients
Open Access
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Conduction and refractory disorders in the diabetic atriumAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial FibrillationThe American Journal of Cardiology, 2011
- Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitusEP Europace, 2011
- Catheter Ablation for Atrial FibrillationJACC, 2011
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trialThe Lancet, 2010
- Diabetes Mellitus, Glycemic Control, and Risk of Atrial FibrillationJournal of General Internal Medicine, 2010
- How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of CardiologyEuropean Heart Journal, 2007
- Obstructive Sleep Apnea, Obesity, and the Risk of Incident Atrial FibrillationJACC, 2007
- Left Ventricular Diastolic Dysfunction in Patients with So‐Called Lone Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2000
- Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.The American Journal of Cardiology, 1998